Saturday, 10 October 2026European Markets

EDP RENOVAVEIS And MAGNORA Have A High Dividend Yield And Return On Equity In The Utilities Sector.

Loading stream...

(VIANEWS) - EDP RENOVAVEIS (EDPR.LS) is among this list of stock assets with the highest dividend rate and return on equity on the Utilities sector.

Financial Asset Price Forward Dividend Yield Return on Equity
EDP RENOVAVEIS (EDPR.LS) €17.49 1.37% 5.24%
MAGNORA (MGN.OL) kr30.80 1.21% 52.28%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. EDP RENOVAVEIS (EDPR.LS)

1.37% Forward Dividend Yield and 5.24% Return On Equity

EDP Renováveis, S.A., a renewable energy company, plans, constructs, operates, and maintains electric power generation plants. The company operates wind and solar farms. As of December 31, 2021, it had an installed capacity of 5,908 megawatts in the United States; 2,194 megawatts in Spain; 795 megawatts in Brazil; and 1,142 megawatts in Portugal. The company was incorporated in 2007 and is headquartered in Madrid, Spain. EDP Renováveis, S.A. operates as a subsidiary of EDP-Energias de Portugal, S.A.

Earnings Per Share

As for profitability, EDP RENOVAVEIS has a trailing twelve months EPS of €0.43.

PE Ratio

EDP RENOVAVEIS has a trailing twelve months price to earnings ratio of 40.66. Meaning, the purchaser of the share is investing €40.66 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.24%.

Moving Average

EDP RENOVAVEIS's worth is way higher than its 50-day moving average of €15.71 and below its 200-day moving average of €18.43.

More news about EDP RENOVAVEIS.

2. MAGNORA (MGN.OL)

1.21% Forward Dividend Yield and 52.28% Return On Equity

Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, MAGNORA has a trailing twelve months EPS of kr3.94.

PE Ratio

MAGNORA has a trailing twelve months price to earnings ratio of 7.82. Meaning, the purchaser of the share is investing kr7.82 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.28%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MAGNORA's EBITDA is 16.31.

Revenue Growth

Year-on-year quarterly revenue growth grew by 271.1%, now sitting on 340.7M for the twelve trailing months.

More news about MAGNORA.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com